Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review
Journal of Diabetes and its Complications, 09/23/09
Schemmel KE et al. – Given the mechanism by which diabetic peripheral neuropathy can result, targeting the polyol pathway as a method of treatment appears promising, yet the efficacy of newer AR inhibitors is still to be proven. Currently, these agents are not marketed in the United States. As newer studies emerge, diabetes educators will learn more about their efficacy and safety in preventing and treating diabetic peripheral neuropathy.
Related Articles
Prevalence and Risk Factors of Somatic and Autonomic Neuropathy in Prediabetic and Diabetic Patients
Neuroepidemiology, 11/11/09
Relevance Score: 98%
Peripheral neuropathy and visual evoked potential changes in workers exposed to n-hexane
Journal of Clinical Neuroscience, 10/06/09
Relevance Score: 98%
Accuracy of Monofilament Testing to Diagnose Peripheral Neuropathy: A Systematic Review
Annals of Family Medicine, 11/10/09
Relevance Score: 97%
Evolution of the phenotype in a family with an LMNA gene mutation presenting with isolated cardiac involvement
Muscle & Nerve, 10/07/09
Relevance Score: 97%
Coping with Neurological Diseases at Home
Internet Source, 11/06/09
Relevance Score: 96%
Today in Diabetes...keeping you current
Receive free subspecialty "5-minute updates" via email
Effect of Raloxifene on Serum Lipids for Type 2 Diabetic Menopausal Women with or without Statin Treatment
Medical Principles and Practice, 12/10/09
Changes in levels of haemoglobin A 1c during the first 6 years after diagnosis of clinical type 2 diabetes
Scandinavian Journal of Clinical and Laboratory Investigation, 12/10/09
Influence of BMI, Age and Duration of Diabetes Mellitus on Glycaemic Control with Twice-Daily Injections of Biphasic Insulin Aspart 30 versus Multiple Daily Injections of Insulin Aspart (JDDM 18): Retrospective Reanalysis of a 6-Month, Randomized, Open-Label, Multicentre Trial in Japan
Clinical Drug Investigation, 12/10/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Effect of Raloxifene on Serum Lipids for Type 2 Diabetic Menopausal Women with or without Statin Treatment
Medical Principles and Practice, 12/10/09
Influence of BMI, Age and Duration of Diabetes Mellitus on Glycaemic Control with Twice-Daily Injections of Biphasic Insulin Aspart 30 versus Multiple Daily Injections of Insulin Aspart (JDDM 18): Retrospective Reanalysis of a 6-Month, Randomized, Open-Label, Multicentre Trial in Japan
Clinical Drug Investigation, 12/10/09
Phase III trial of chemotherapy using 5-fluorouracil and streptozotocin compared with interferon alpha for advanced carcinoid tumors: FNCLCC–FFCD 9710
Endocrine-Related Cancer, 12/10/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


